Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Bowel Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT00725400
What this trial is testing

Comparative Study of Cetuximab and Radiation Vs Surgery Before or After Radiation in Patients With Colorectal Carcinoma

Who this might be right for
Colorectal Carcinoma
American Scitech International 450
Not applicableStudy completedNCT06244836
What this trial is testing

Comparison of Two Bundles of Care to Reduce Surgical Site Infection in Colorectal Surgery (CCR-VINCat 2)

Who this might be right for
Colon CancerRectal CancerSurgical Site Infection
Hospital de Granollers 32,205
Not applicableLooking for participantsNCT07816536
What this trial is testing

Gut Microbiota Changes in Children Receiving Exclusive Enteral Nutrition With Compleat® Paediatric

Who this might be right for
Feeding and Eating Disorders of ChildhoodEnteral Nutrition Dependence
Establishment for Children and Adolescents in the Nantes Region 8
Post-approval studies (Phase 4)Study completedNCT00688636
What this trial is testing

Infliximab for the Prevention of Recurrent Crohn's Disease After Surgery

Who this might be right for
Crohn's Disease
University of Pittsburgh 24
Not applicableStudy completedNCT02322736
What this trial is testing

Prospective Observational Study of 1st and 2nd Line Vectibix® Use in RAS-wt mCRC Pts to Evaluate Pattern of Use and ORR

Who this might be right for
Metastatic Colorectal Cancer
Amgen 218
Not applicableStudy completedNCT07072871
What this trial is testing

Effect of Lactiplantibacillus Plantarum DAD-13 on Inflammatory Markers in ICU Sepsis Patients

Who this might be right for
SepsisSystemic Inflammatory Response Syndrome (SIRS)Critical Illness
PT Royal Medikalink Pharmalab 30
Testing effectiveness (Phase 2)Study completedNCT00000771
What this trial is testing

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3

Who this might be right for
CryptosporidiosisHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 68
Not applicableLooking for participantsNCT06221800
What this trial is testing

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

Who this might be right for
Non Small Cell Lung Cancer
University of California, Irvine 82
Not applicableWithdrawnNCT00640692
What this trial is testing

Kinase Genotyping of Gastro Intestinal Stomach Tumors (GISTs) From Patients Enrolled in Pfizer A6181112 Phase IIIb Trial

Who this might be right for
Gastrointestinal Neoplasm
Oregon Health and Science University
Testing effectiveness (Phase 2)Study completedNCT00807911
What this trial is testing

Adjuvant Chemotherapy After Preoperative Chemoradiotherapy to Treat Rectal Cancer

Who this might be right for
Rectal Cancer
Asan Medical Center 322
Testing effectiveness (Phase 2)WithdrawnNCT03879811
What this trial is testing

Determining the Effects of Temozolomide Followed by Nivolumab in Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01111292
What this trial is testing

Inositol in Preventing Colorectal Cancer in Patients With Colitis-Associated Dysplasia

Who this might be right for
Colon CarcinomaDysplasia in Crohn DiseaseLow Grade Dysplasia in Ulcerative Colitis+1 more
National Cancer Institute (NCI) 5
Large-scale testing (Phase 3)Study completedNCT03524092
What this trial is testing

A Maintenance Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Eli Lilly and Company 1,328
Not applicableStudy completedNCT06907407
What this trial is testing

Effect Of Different Diaphragmatic Myofascial Release Approaches On Low Back Pain And Quality Of Life Among Young Females With Irritable Bowel Syndrome

Who this might be right for
Irritable Bowel Syndrome
Cairo University 90
Large-scale testing (Phase 3)Study completedNCT00000611
What this trial is testing

Women's Health Initiative (WHI)

Who this might be right for
Bone DiseasesBreast NeoplasmsCardiovascular Diseases+6 more
National Heart, Lung, and Blood Institute (NHLBI)
Not applicableActive Not RecruitingNCT05633771
What this trial is testing

Observational Study, to Assess Treatment Retention of an Adalimumab Biosimilar (Hyrimoz®) in IBD Patients in Real Life Setting

Who this might be right for
Inflammatory Bowel Disease
Sandoz 562
Not applicableStudy completedNCT00728026
What this trial is testing

Autonomic Profiles in Pediatric Patients With Cyclic Vomiting Syndrome (CVS), Irritable Bowel Syndrome (IBS),Postural Orthostatic Tachycardia Syndrome (POTS), Functional Abdominal Pain (FAP) or Chronic Nausea

Who this might be right for
Vomiting SyndromeIrritable Bowel SyndromePostural Orthostatic Tachycardia Syndrome+2 more
Medical College of Wisconsin 19
Not applicableActive Not RecruitingNCT05874726
What this trial is testing

Biological Sample Repository for Gastrointestinal Disorders

Who this might be right for
ObesityObesity, MorbidObesity, Primary+14 more
Pichamol Jirapinyo, MD, MPH 500
Large-scale testing (Phase 3)Looking for participantsNCT07450443
What this trial is testing

Role of the Gut Vascular Barrier and Microbiota in Autism Spectrum Disorders

Who this might be right for
AutismAutism DisorderAutism Spectrum Disorder (ASD)
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta 90
Testing effectiveness (Phase 2)Ended earlyNCT00531115
What this trial is testing

Phase II Study to Evaluate Safety and Efficacy of Cetuximab in Combination With XELOX for 12 Weeks Followed by Maintenance Treatment With Cetuximab Plus Capecitabine as First-line Treatment in Elderly Patients With Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) 28
Next Page